Rice Partnership, LLC Abbott Laboratories Transaction History

Rice Partnership, LLC

$512 Million
Q4 2024

A detailed history of Rice Partnership, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Rice Partnership, LLC holds 16,969 shares of ABT stock, worth $2.34 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

16,969

Previous 17,259 1.68%

Holding current value

$2.34 Million

Previous $1.97 Million 2.44%

% of portfolio

0.37%

Previous 0.41%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	SELL	$111.93 - $119.39 $32,459 - $34,623	-290 Reduced 1.68%	16,969 $1.92 Million
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $500 - $590	-5 Reduced 0.03%	17,259 $1.97 Million
Q2 2024 Aug 01, 2024	SELL	$100.73 - $112.44 $33,845 - $37,779	-336 Reduced 1.91%	17,264 $1.79 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $501,820 - $554,238	-4,582 Reduced 20.66%	17,600 $2 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $510,836 - $625,305	-5,664 Reduced 20.34%	22,182 $2.44 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $133,550 - $160,238	-1,398 Reduced 4.78%	27,846 $2.7 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $227,258 - $253,213	-2,255 Reduced 7.16%	29,244 $3.19 Million
Q1 2023 Apr 27, 2023	SELL	$96.86 - $114.01 $111,485 - $131,225	-1,151 Reduced 3.53%	31,499 $3.19 Million
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $1.93 Million - $2.26 Million	-20,280 Reduced 38.31%	32,650 $0
Q3 2022 Nov 02, 2022	SELL	$96.76 - $112.03 $822,653 - $952,479	-8,502 Reduced 13.84%	52,930 $5.12 Million
Q2 2022 Jul 22, 2022	SELL	$102.07 - $123.37 $1.92 Million - $2.33 Million	-18,850 Reduced 23.48%	61,432 $6.68 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $204,665 - $249,576	1,795 Added 2.29%	80,282 $9.5 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $85,261 - $104,397	738 Added 0.95%	78,487 $11 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $117,943 - $130,479	1,011 Added 1.32%	77,749 $9.18 Million
Q2 2021 Aug 04, 2021	SELL	$105.79 - $124.53 $464,629 - $546,935	-4,392 Reduced 5.41%	76,738 $8.9 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $37,985 - $44,752	-349 Reduced 0.43%	81,130 $9.72 Million
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $145,530 - $158,586	1,386 Added 1.73%	81,479 $8.92 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $645,328 - $783,704	7,042 Added 9.64%	80,093 $8.72 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $5.59 Million - $7.16 Million	73,051 New	73,051 $6.68 Million
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $3.85 Million - $5.63 Million	-61,270 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$78.51 - $87.4 $307,523 - $342,345	3,917 Added 6.83%	61,270 $5.32 Million
Q3 2019 Nov 07, 2019	BUY	$81.84 - $88.74 $259,105 - $280,950	3,166 Added 5.84%	57,353 $4.8 Million
Q2 2019 Jul 25, 2019	BUY	$72.88 - $85.0 $413,448 - $482,205	5,673 Added 11.69%	54,187 $4.56 Million
Q1 2019 May 06, 2019	BUY	$66.22 - $80.06 $226,803 - $274,205	3,425 Added 7.6%	48,514 $3.88 Million
Q4 2018 Jan 22, 2019	BUY	$65.56 - $74.27 $109,091 - $123,585	1,664 Added 3.83%	45,089 $3.26 Million
Q3 2018 Nov 15, 2018	BUY	$60.81 - $73.36 $101,674 - $122,657	1,672 Added 4.0%	43,425 $3.19 Million
Q2 2018 Aug 21, 2018	BUY	$57.57 - $63.54 $352,040 - $388,547	6,115 Added 17.16%	41,753 $2.55 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $57,451 - $64,956	1,021 Added 2.95%	35,638 $2.14 Million
Q4 2017 May 14, 2018	BUY	$53.68 - $57.47 $1.86 Million - $1.99 Million	34,617	34,617 $1.98 Million

Others Institutions Holding ABT

# of Institutions

3,371

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $242B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Partnership, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Partnership, LLC with notifications on news.

Account

Rice Partnership, LLC Abbott Laboratories Transaction History